Nash, Richard A

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS. [electronic resource] - Neurology Feb 2017 - 842-852 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

1526-632X

10.1212/WNL.0000000000003660 doi


Adult
Disability Evaluation
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Immunosuppressive Agents--administration & dosage
Magnetic Resonance Imaging
Male
Multiple Sclerosis, Relapsing-Remitting--diagnostic imaging
Transplantation, Autologous--adverse effects
Treatment Outcome